Impax's Turnaround: Investment Performance Inflects, but Flows Lag

Specialist asset manager sees 70% of AUM beat benchmarks, yet net outflows persist; cost discipline and strong balance sheet set the stage.

IPX.L · Earnings Call · 2026-05-20

Investment Performance Inflects After Years of AI-Driven Headwinds

Impax Asset Management's interim results for the six months to 31 March 2026 deliver a clear message: investment performance has turned the corner. CEO Ian Simm reported that 70% of assets under management beat their benchmarks in the calendar year-to-date through April, a sharp reversal from the prior two to three years when the AI-dominated market skewed returns in favour of generic indices. The cause is straightforward: “If the investment performance is good, then the flows follow.” — Ian Simm, CEO · 2026-05-20 While flows have yet to turn positive, the lag is typical, and the firm is positioning for the recovery. The backdrop is a market that is broadening. Simm highlighted energy security as a major tailwind, especially with the Iran situation: “concerns around energy security, particularly heightened by the Iran situation, which in May 2026 is a major topic.” — Ian Simm, CEO · 2026-05-20 This, combined with a persistent need for resource efficiency and climate adaptation, underpins Impax's thematic strategies.

Net Outflows Persist, but IEM Tender Opens a New Chapter

Despite the performance revival, net outflow remains the defining challenge. CFO Karen Cockburn detailed that revenue fell to GBP 58.8 million from GBP 65.4 million, with the GBP 3.8 million net outflow being the primary driver. The company is guiding to full-year revenue of GBP 109–113 million and an operating fee margin of 47–48 basis points: “we remain committed to that. And across the course of the year, [indiscernible] operating fee margin, excuse me, to remain in the region of 47 to 48 basis points.” — Karen Cockburn, CFO · 2026-05-20 A pivotal event is the exit tender from the IEM investment trust, which saw GBP 740 million flow out. Impax is aggressively courting those investors to switch into its Irish UCITS vehicle, which offers the same underlying strategy. Simm emphasised the product's uniqueness:

This is a unique investment product, and we're offering an attractive route to give the clients of that trust access to that investment idea through the UCITS fund.
Ian Simm, CEO · 2026-05-20

The company is also doubling down on client partnership as a growth lever, with new product launches including its first U.S. ETF and continued investment in fixed income and private markets.

Cost Discipline and Balance Sheet Strength Underpin the Strategy

Impax has been resolute on costs, cutting headcount by 9% in the period with another 30 redundancies planned. Operating costs fell to GBP 47.5 million, down more than GBP 8 million year-on-year, which helped support an operating margin of 19.2%. The company maintains a debt-free balance sheet with GBP 106 million of shareholder equity and announced a 2p interim dividend, consistent with its 55% payout policy. The discipline is deliberate, positioning the firm to capture the upside when revenue stabilises. As Simm put it: “we've got a very ruthless focus with the Board on both cost management but also talent retention.” — Ian Simm, CEO · 2026-05-20 Looking forward, the firm is banking on the bifurcation of the asset management industry, where specialised boutiques like Impax gain share as large players retreat from sustainability-focused strategies. The long-term vision was articulated in the summary: “We do find ourselves as a global leader in a particularly appealing area of the market.” — Ian Simm, CEO · 2026-05-20 The prior quarters echoed similar themes. In the December 2025 call, Simm discussed client stickiness: “there's two types of clients that we've seen recently, the long-term clients that have been with us for 5 to 25 years and then the more recently arrived clients.” — Ian Simm, Chief Executive Officer · 2025-12-03 And Karen Cockburn highlighted the scaling opportunity in fixed income: “We have a 10-year track record. So our investments have been made in that area that really should be scaled – that will – is our main opportunity for scaling.” — Karen Cockburn, Chief Financial Officer · 2025-12-03 These consistent messages underscore that while performance is inflecting, the patient build-out of diversified products and disciplined costs are the strategic anchors. Impax appears well placed to convert its reviving investment record into positive flows, but the timing remains uncertain.